Elicio initiates Phase II pancreatic cancer vaccine trial
Elicio Therapeutics has initiated the Phase II AMPLIFY-7P clinical trial of its investigational therapeutic cancer vaccine, ELI-002 7P, designed to treat Kirsten Rat Sarcoma (KRAS)-mutated PDAC. […]
Elicio initiates Phase II pancreatic cancer vaccine trial Read More »